179 related articles for article (PubMed ID: 35001)
1. Chronic graft versus host disease: a syndrome of disordered immunity.
Graze PR; Gale RP
Am J Med; 1979 Apr; 66(4):611-20. PubMed ID: 35001
[TBL] [Abstract][Full Text] [Related]
2. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.
Shulman HM; Sullivan KM; Weiden PL; McDonald GB; Striker GE; Sale GE; Hackman R; Tsoi MS; Storb R; Thomas ED
Am J Med; 1980 Aug; 69(2):204-17. PubMed ID: 6996481
[TBL] [Abstract][Full Text] [Related]
3. Studies on cellular inhibition and serum-blocking factors in 28 human patients given marrow grafts from HLA identical siblings.
Tsoi MS; Storb R; Weiden PL; Thomas ED
J Immunol; 1977 May; 118(5):1799-805. PubMed ID: 16061
[TBL] [Abstract][Full Text] [Related]
4. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
6. Autoimmunity after allogeneic bone marrow transplantation. A study of 53 long-term-surviving patients.
Rouquette-Gally AM; Boyeldieu D; Prost AC; Gluckman E
Transplantation; 1988 Aug; 46(2):238-40. PubMed ID: 3043780
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal radiographic features of human graft-vs.-host disease.
Fisk JD; Shulman HM; Greening RR; McDonald GB; Sale GE; Thomas ED
AJR Am J Roentgenol; 1981 Feb; 136(2):329-36. PubMed ID: 6781255
[TBL] [Abstract][Full Text] [Related]
8. Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation.
Min CK; Kim DW; Lee JW; Min WS; Kim CC
Acta Haematol; 2000; 104(4):185-92. PubMed ID: 11279309
[TBL] [Abstract][Full Text] [Related]
9. Graft-versus-host disease after marrow transplantation.
Storb R
Prog Clin Biol Res; 1986; 224():139-57. PubMed ID: 3540990
[TBL] [Abstract][Full Text] [Related]
10. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
[TBL] [Abstract][Full Text] [Related]
11. Chronic cutaneous graft-versus-host disease in man.
Shulman HM; Sale GE; Lerner KG; Barker EA; Weiden PL; Sullivan K; Gallucci B; Thomas ED; Storb R
Am J Pathol; 1978 Jun; 91(3):545-70. PubMed ID: 26221
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.
Ikegame K; Yoshihara S; Taniguchi Y; Kaida K; Inoue T; Okada M; Taniguchi K; Hasei H; Tamaki H; Fujioka T; Kato R; Soma T; Ogawa H
Exp Hematol; 2011 Aug; 39(8):880-90. PubMed ID: 21689724
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation.
Drobyski WR; Potluri J; Sauer D; Gottschall JL
Bone Marrow Transplant; 1996 Jun; 17(6):1093-9. PubMed ID: 8807120
[TBL] [Abstract][Full Text] [Related]
14. A clinicopathological study of 15 autopsy cases with allogeneic bone marrow transplantation in special reference to graft versus host disease (GVHD).
Nakamura N
Acta Pathol Jpn; 1986 May; 36(5):641-64. PubMed ID: 3526810
[TBL] [Abstract][Full Text] [Related]
15. [Graft versus host reaction and hybrid resistance in experimental models and clinical practice].
Clerici M; Villa ML; Clerici E
Boll Ist Sieroter Milan; 1988; 67(3):177-96. PubMed ID: 3072013
[TBL] [Abstract][Full Text] [Related]
16. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
[TBL] [Abstract][Full Text] [Related]
18. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
[TBL] [Abstract][Full Text] [Related]
19. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
Koehler M; Hurwitz CA; Krance RA; Coustan-Smith E; Williams LL; Santana V; Ribeiro RC; Brenner MK; Heslop HE
Bone Marrow Transplant; 1994 May; 13(5):571-5. PubMed ID: 7519937
[TBL] [Abstract][Full Text] [Related]
20. Marrow transplant experience for children with severe aplastic anemia.
Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J
Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
